Vai al contenuto principale della pagina

tPA for stroke [[electronic resource] ] : the story of a controversial drug / / Justin A. Zivin, John Galbraith Simmons



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Zivin Justin A Visualizza persona
Titolo: tPA for stroke [[electronic resource] ] : the story of a controversial drug / / Justin A. Zivin, John Galbraith Simmons Visualizza cluster
Pubblicazione: New York, : Oxford University Press, 2011
Descrizione fisica: 1 online resource (206 p.)
Disciplina: 616.8/106
Soggetto topico: Cerebrovascular disease - Chemotherapy - History
Tissue plasminogen activator - Therapeutic use - History
Altri autori: SimmonsJohn <1949->  
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: Code stroke on Market street -- Clot-buster : the natural history -- Dead or alive -- Brain-O -- The brain doctors cometh : slowly -- What emergency? -- Money and brains -- Deer in the headlights -- Call 911, 112, 15 ... even 999 -- Persistence of a most controversial drug -- Through the looking glass -- Post-script.
Sommario/riassunto: Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua
Titolo autorizzato: TPA for stroke  Visualizza cluster
ISBN: 1-283-12126-3
9786613121264
0-19-978094-3
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910790079203321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui